AU5973600A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: AU5973600A
Authority: AU; Australia
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1999-06-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU59736/00A

Inventor

Ian Charles Kilpatrick

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott GmbH and Co KG

Original Assignee

Knoll GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-24

Filing date

2000-06-16

Publication date

2001-01-31

2000-06-16 Application filed by Knoll GmbH filed Critical Knoll GmbH

2001-01-31 Publication of AU5973600A publication Critical patent/AU5973600A/en

Status Abandoned legal-status Critical Current

Links

239000003814 drug Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

AU59736/00A 1999-06-24 2000-06-16 Therapeutic agents Abandoned AU5973600A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9914745		1999-06-24
GBGB9914745.6A GB9914745D0 (en)	1999-06-24	1999-06-24	Therapeutic agents
PCT/EP2000/005541 WO2001000185A2 (en)	1999-06-24	2000-06-16	1,4-denzothiazepines to treat obesity related disorders

Publications (1)

Publication Number	Publication Date
AU5973600A true AU5973600A (en)	2001-01-31

Family

ID=10855956

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU59736/00A Abandoned AU5973600A (en)	1999-06-24	2000-06-16	Therapeutic agents

Country Status (7)

Country	Link
EP (1)	EP1218010A2 (en)
JP (1)	JP2003513008A (en)
AU (1)	AU5973600A (en)
CA (1)	CA2376023A1 (en)
GB (1)	GB9914745D0 (en)
MX (1)	MXPA01013420A (en)
WO (1)	WO2001000185A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8710045B2 (en)	2004-01-22	2014-04-29	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) *	2005-08-25	2010-04-27	The Trustees Of Columbia University In The City Of New York	Agents for preventing and treating disorders involving modulation of the RyR receptors
JP5497429B2 (en) *	2007-03-07	2014-05-21	武田薬品工業株式会社	Benzoxazepine derivatives and uses thereof
EP2358716B1 (en)	2008-11-12	2016-01-06	Merck Sharp & Dohme Corp.	Inhibitors of fatty acid binding protein (fabp)
WO2013064231A1 (en)	2011-10-31	2013-05-10	Phenex Pharmaceuticals Ag	SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
EP2708535A1 (en)	2012-05-11	2014-03-19	Les Laboratoires Servier	Agents for treating disorders involving modulation of ryanodine receptors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3361760A (en) *	1963-03-21	1968-01-02	Squibb & Sons Inc	Benzothiazepines
US3794639A (en) *	1966-03-10	1974-02-26	Squibb & Sons Inc	Benzoxazepines and benzothiazepines
JP2871811B2 (en) *	1990-02-28	1999-03-17	サントリー株式会社	7-membered condensed ring compound
GB9203347D0 (en) *	1992-02-17	1992-04-01	Wellcome Found	Hypolipidaemic compounds
JP3093419B2 (en) *	1992-03-30	2000-10-03	麒麟麦酒株式会社	1,4-benzothiazepine derivatives
KR100313649B1 (en) *	1992-11-09	2002-02-28	더 부츠 캄파니 피엘씨	1,4-benzothiazepine useful as a therapeutic agent for neurological diseases, preparation method thereof, and pharmaceutical composition comprising the same
EP0673371A1 (en) *	1992-12-11	1995-09-27	Novartis AG	Benzazepinone derivatives
ZA941003B (en) *	1993-02-15	1995-08-14	Wellcome Found	Hypolipidaemic compounds
IL108634A0 (en) *	1993-02-15	1994-05-30	Wellcome Found	Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
ZA956647B (en) *	1994-08-10	1997-02-10	Wellcome Found	Hypolipidaemic compounds.
ES2198613T3 (en) *	1997-03-14	2004-02-01	Aventis Pharma Deutschland Gmbh	1,4-BENZOTIAZEPINA-1,1-HYPOLIPIDEMIC DIOXIDES.
ES2275313T3 (en) *	1997-08-22	2007-06-01	Kaken Pharmaceutical Co., Ltd.	DERIVATIVES OF AMIDA AS PROMOTERS OF THE RELEASE OF THE HORMONE OF GROWTH.

1999
- 1999-06-24 GB GBGB9914745.6A patent/GB9914745D0/en not_active Ceased
2000
- 2000-06-16 MX MXPA01013420A patent/MXPA01013420A/en unknown
- 2000-06-16 WO PCT/EP2000/005541 patent/WO2001000185A2/en not_active Application Discontinuation
- 2000-06-16 AU AU59736/00A patent/AU5973600A/en not_active Abandoned
- 2000-06-16 EP EP00945759A patent/EP1218010A2/en not_active Withdrawn
- 2000-06-16 CA CA002376023A patent/CA2376023A1/en not_active Abandoned
- 2000-06-16 JP JP2001505895A patent/JP2003513008A/en not_active Withdrawn

Also Published As

Publication number	Publication date
MXPA01013420A (en)	2002-07-22
WO2001000185A3 (en)	2002-04-11
WO2001000185A2 (en)	2001-01-04
EP1218010A2 (en)	2002-07-03
GB9914745D0 (en)	1999-08-25
JP2003513008A (en)	2003-04-08
CA2376023A1 (en)	2001-01-04

Legal Events

Date	Code	Title	Description
2002-04-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
HK1200316A1 (en)	2015-08-07	Therapeutic microfoams
AU2001252135A1 (en)	2001-09-03	Therapeutic agents
EP1212327B8 (en)	2004-02-25	Pyrazolopyrimidines as therapeutic agents
GB9911863D0 (en)	1999-07-21	Therapeutic agents
GB9905010D0 (en)	1999-04-28	Therapeutic agents
AU5259100A (en)	2000-11-10	Medicament
IL150030A0 (en)	2002-12-01	Therapeutic agents
GB9904786D0 (en)	1999-04-28	Therapeutic agents
GB9929685D0 (en)	2000-02-09	Therapeutic agents
GB9929687D0 (en)	2000-02-09	Therapeutic agents
GB9911881D0 (en)	1999-07-21	Therapeutic agents
GB9921351D0 (en)	1999-11-10	Therapeutic agents
AU2451500A (en)	2000-09-04	Therapeutic agents
GB9929569D0 (en)	2000-02-09	Therapeutic agents
GB9914744D0 (en)	1999-08-25	Therapeutic agents
AU2001273903A1 (en)	2001-10-08	Therapeutic agents
GB9903119D0 (en)	1999-04-07	Therapeutic agents
AU5973600A (en)	2001-01-31	Therapeutic agents
GB9914742D0 (en)	1999-08-25	Therapeutic agents
GB9902881D0 (en)	1999-03-31	Therapeutic agents
AU2001275696A1 (en)	2002-02-05	Therapeutic agent
AU6150200A (en)	2001-01-31	Therapeutic agents
AU5817400A (en)	2001-01-22	Therapeutic agents
AU6302300A (en)	2001-02-19	Therapeutic agents
AU5817500A (en)	2001-01-22	Therapeutic agents